Correction: Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer
Hanwen Zhang(Qilu Hospital of Shandong University), Qifeng Yang(Qilu Hospital of Shandong University), Zhaojian Liu(Shandong University), Haiyang Guo(Shandong University), Yi Duan(University of California, San Diego), Peng Su(Qilu Hospital of Shandong University), Yuting Sang(Qilu Hospital of Shandong University), Ning Zhang(Qilu Hospital of Shandong University), Ying Liu(Guilin Medical University), Xiaolong Wang(Qilu Hospital of Shandong University), Lijuan Wang(Nanjing Medical University), Bing Chen(Shandong University), Tong Chen(The Ohio State University), Yaming Li(Qilu Hospital of Shandong University), Xiaojin Song(Qilu Hospital of Shandong University), Wenjing Zhao(Qilu Hospital of Shandong University), Jiashu Zhang(Qilu Hospital of Shandong University), Yiran Liang(Qilu Hospital of Shandong University), Guohong Hu(Shanghai Jiao Tong University)
Cited by 92
Related Papers
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
|Seminars in Cancer Biology|2019|1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
m6A RNA Methylation Is Regulated by MicroRNAs and Promotes Reprogramming to Pluripotency
|Cell stem cell|2015|553